Quality of life aspects in the management of thyroid cancer

Oral Oncology

Volumn 51, Issue 6, 2015, Pages S1-S5

  Duan, H ^a   Gamper, E ^b   Becherer, A ^c   Hoffmann, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Academic Teaching Hospital Feldkirch   (Austria)

Author keywords

Cancer management; Meeting report; Patient reported outcomes; Quality of life; Thyroid cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL PRACTICE; CONVERSATION; FEMALE; HUMAN; INCIDENCE; LEARNING; MEDICAL INFORMATION; MIDDLE AGED; MORTALITY; ONCOLOGY; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; PSYCHOLOGIST; QUALITY OF LIFE; THYROID CANCER; VOLUNTEER; HEALTH PERSONNEL ATTITUDE; PATIENT; PSYCHOLOGY; THYROID NEOPLASMS; TREATMENT OUTCOME;

ATTITUDE OF HEALTH PERSONNEL; HUMANS; PATIENTS; PHYSICIANS; PSYCHOLOGY; QUALITY OF LIFE; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 84929132384     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2015.03.008     Document Type: Article

References (24)

1. J. Easley, B. Miedema, and L. Robinson It's the 'Good' cancer, so who cares? Perceived lack of support among young thyroid cancer survivors Oncol Nurs Forum 40 6 2013 596 600
2. STATISTIK AUSTRIA. Krebsinzidenz (Neuerkrankungen pro Jahr)/Krebsmortalität (Sterbefälle pro Jahr), [accessed 02.01.14].
3. C. La Vecchia, M. Malvezzi, C. Bosetti, W. Garavello, P. Bertuccio, and F. Levi et al. Thyroid cancer mortality and incidence: a global overview Int J Cancer 2014 10.1002/ijc.26251 October 4. [Epub ahead of print]
4. C. Bal, A. Kumar, M. Tripathi, N. Chandrashekar, H. Phom, and N.R. Murali et al. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring Int J Radiat Oncol Biol Phys 63 2005 449 455
5. S. Hyer, L. Vini, M. O'Connell, B. Pratt, and C. Harmer Testicular dose and fertility in men following I(131) therapy for thyroid cancer Clin Endocrinol (Oxf) 56 2002 755 758
6. J. Klubo-Gwiezdzinska, K.D. Burman, D. Van Nostrand, M. Mete, J. Jonklaas, and L. Wartofsky Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin Thyroid 22 2012 310 317
7. S. Hyer, A. Kong, B. Pratt, and C. Harmer Salivary gland toxicity after radioiodine therapy for thyroid cancer Clin Oncol (R Coll Radiol) 19 2007 83 86
8. M.D. Brundage, J.L. Pater, and B. Zee Assessing the reliability of two toxicity scales: implications for interpreting toxicity data J Natl Cancer Inst 85 14 1993 1138 1148
9. J. Myers, K. Gardiner, K. Harris, T. Lilien, M. Bennett, and E. Chow et al. Evaluating correlation and interrater reliability for four performance scales in the palliative care setting J. Pain Symptom Manage 39 2 2010 250 258
10. E. Basch, X. Jia, G. Heller, A. Barz, L. Sit, and M. Fruscione et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes J Natl Cancer Inst 101 23 2009 1624 1632
11. F. Efficace, G. Rosti, N. Aaronson, F. Cottone, E. Angelucci, and S. Molica et al. Patient versus physician symptom and health status reporting in chronic myeloid leukemia Haematologica 2013 November 15. [Epub ahead of print]
12. A. Trotti, A.D. Colevas, A. Setser, and E. Basch Patient-reported outcomes and the evolution of adverse event reporting in oncology J Clin Oncol 25 32 2007 5121 5127
13. FDA: Guidance for Industry. Patient-reported outcome measures: use in medical product development to support labeling claims. December 2009, < http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm193282.pdf > [accessed 02.01.14].
14. G. Velikova, D. Stark, and P. Selby Quality of life instruments in oncology Eur J Cancer 35 11 1999 1571 1580
15. K.H. Dow, B.R. Ferrell, and C. Anello Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy Thyroid 7 4 1997 613 619
16. M. Luster, R. Felbinger, M. Dietlein, and C. Reiners Thyroid hormone withdrawal in patients with differentiated thyroid carcinoma: a one hundred thirty-patient pilot survey on consequences of hypothyroidism and a pharmacoeconomic comparison to recombinant thyrotropin administration Thyroid 15 10 2005 1147 1155
17. S. Tagay, S. Herpertz, M. Langkafel, Y. Erim, L. Freudenberg, and N. Schöpper et al. Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment Eur J Endocrinol 153 6 2005 755 763
18. P.R. Schroeder, B.R. Haugen, F. Pacini, C. Reiners, M. Schlumberger, and S.I. Sherman et al. A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal J Clin Endocrinol Metab 91 3 2006 878 884
19. D. Taïeb, F. Sebag, M. Cherenko, K. Baumstarck-Barrau, C. Fortanier, and B. Farman-Ara et al. Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study Clin Endocrinol (Oxf) 71 1 2009 115 123
20. J. Lee, M.J. Yun, K.H. Nam, W.Y. Chung, E.Y. Soh, and C.S. Park Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma Thyroid 20 2 2010 173 179
21. R. Crevenna, G. Zettinig, M. Keilani, M. Posch, M. Schmidinger, and C. Pirich et al. Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy Support Care Cancer 11 9 2003 597 603
22. H. Pelttari, H. Sintonen, C. Schalin-Jäntti, and M.J. Välimäki Health-related quality of life in long-term follow-up of patients with cured TNM Stage I or II differentiated thyroid carcinoma Clin Endocrinol (Oxf) 70 3 2009 493 497
23. L.G. Tan, L. Nan, J. Thumboo, F. Sundram, and L.K. Tan Health-related quality of life in thyroid cancer survivors Laryngoscope 117 3 2007 507 510
24. S. Singer, T. Lincke, E. Gamper, K. Bhaskaran, S. Schreiber, and A. Hinz et al. Quality of life in patients with thyroid cancer compared with the general population Thyroid 22 2 2012 117 124